title: Does size really matter? Analysis of the effect of large fibroids and uterine volumes on complication rates of uterine artery embolisation.
abstract: The purpose of this study was to determine whether there is a correlation between large uterine fibroid diameter, uterine volume, number of vials of embolic agent used and risk of complications from uterine artery embolisation (UAE). This was a prospective study involving 121 patients undergoing UAE embolisation for symptomatic uterine fibroids at a single institution. Patients were grouped according to diameter of largest fibroid and uterine volume. Results were also stratified according to the number of vials of embolic agent used and rate of complications. No statistical difference in complication rate was demonstrated between the two groups according to diameter of the largest fibroid (large fibroids were classified as > or = 10 cm; Fisher's exact test P = 1.00), and no statistical difference in complication rate was demonstrated according to uterine volume (large uterine volume was defined as > or = 750 cm(3); Fisher's exact test P = 0.70). 84 of the 121 patients had documentation of the number of vials used during the procedure. Patients were divided into two groups, with > or = 4 used defined as a large number of embolic agent. There was no statistical difference between these two groups and no associated increased risk of developing complications. This study showed no increased incidence of complications in women with large-diameter fibroids or uterine volumes as defined. In addition, there was no evidence of increased complications according to quantity of embolic material used. Therefore, UAE should be offered to women with large fibroids and uterine volumes.
authors.affiliation: Department of Radiology, St. George's Hospital, London, UK. aneeta@hotmail.co.uk
authors.forename: A A
authors.initials: AA
authors.lastname: Parthipun
authors.forename: J
authors.initials: J
authors.lastname: Taylor
authors.forename: I
authors.initials: I
authors.lastname: Manyonda
authors.forename: A M
authors.initials: AM
authors.lastname: Belli
mesh_terms: D000328:Adult; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007889:Leiomyoma / Q000000981:diagnostic imaging / Q000473:pathology* / Q000628:therapy*; D008875:Middle Aged; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000175:diagnosis / Q000453:epidemiology; D012016:Reference Values; D012189:Retrospective Studies; D018570:Risk Assessment; D016896:Treatment Outcome; D047368:Tumor Burden; D018608:Ultrasonography, Doppler; D055357:Uterine Artery Embolization / Q000009:adverse effects* / Q000379:methods; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000628:therapy*